MedPath

Waist Circumference Versus Body Mass Index to Predict Severity of Gastroesophageal Reflux Disease

Completed
Conditions
Gastroesophageal Reflux Disease
Obesity
Interventions
Other: Anthropometric measurements
Registration Number
NCT00698178
Lead Sponsor
Lotung Poh-Ai Hospital
Brief Summary

Gastroesophageal reflux disease (GERD) is a common and important disorder. Previous studies have demonstrated the association of obesity with GERD, and now obesity is regarded as a risk factor for GERD. Moreover, body mass index (BMI), an indicator of general obesity, correlates with severity of symptoms and degree of erosive esophagitis. Waist circumference, an indicator of abdominal obesity, has stronger correlation with intra-abdominal pressure and low-grade inflammatory state when compared with BMI. Nevertheless the association of waist circumference with severity of GERD has not been studied.

The primary aim of this study is to compare BMI with waist circumference for their independent association with severity of GERD. The secondary aim is to evaluate independent risk factors of severity of GERD.

Detailed Description

This is a cross-section observational study. Outpatients presenting with acid reflux or heart burn are interviewed with standardized questionnaire to quantify severity of symptoms. The eligible patients undergo upper endoscopy to diagnose erosive esophagitis and further classify the degree of erosions according to Los-Angels classification. Enrolled patients receive anthropometric measurements to record body weight, body height and waist circumference on the day of enrollment.

Two outcomes are studied: the severity of GERD symptoms and the Los-Angels Classification of erosive esophagitis.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
500
Inclusion Criteria
  • age more than 20 years old and less than 70 years old
  • typical gastroesophageal reflux symptoms (heart burn and acid reflux)
  • outpatient
  • complete upper gastrointestinal endoscopy
Exclusion Criteria
  • age less than 20 years or more than 70 years old
  • receive medication for reflux disease (including proton pump inhibitor, histamine type 2 receptor blocker, prokinetic agents) in previous one month
  • pregnant women
  • history of abdominal surgery
  • severe comorbidity with cirrhosis, end-stage renal disease, heart failure
  • no written informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
EEAnthropometric measurementsPatients with both typical gastroesophageal reflux symptoms and characteristic flam-like erosions as demonstrated on upper gastrointestinal endoscopy
NERDAnthropometric measurementspatients with typical gastro-reflux symptoms but no erosions were discernible on upper gastrointestinal endoscopy
FDAnthropometric measurementsPatients report no typical reflux symptoms but fulfill diagnostic criteria of functional dyspepsia, whose upper gastrointestinal endoscopy are negative.
Primary Outcome Measures
NameTimeMethod
the degree fo erosive esophagitis according to Los-Angels classificationon the day of endoscopy examination
Secondary Outcome Measures
NameTimeMethod
gastro-reflux severity score as evaluated by standardized questionnaireat enrollment (before upper GI endoscopy)

Trial Locations

Locations (1)

Lotung Poh-Ai Hospital

🇨🇳

Lotung Town, Ilan County, Taiwan

© Copyright 2025. All Rights Reserved by MedPath